Arthritis Clinic

371 North Parkway, Suite 400
Jackson, TN 38301
731-664-0002 • 866-5564-0011

Jacob Aelion, M.D.
Satish Odhav, M.D.

Founded by Dr. Aelion and Dr. Odhav, the Arthritis Clinic specializes in the treatment of rheumatolgical conditions, such as rheumatoid arthritis, osteoarthritis, lupus, fibromyalgia, gout, tendonitis, bursitis, and metabolic bone diseases, such as osteoporosis. Dr. Dayal joined the clinic in January 2011. The clinic has active clinical research trials in a number of rheumatological conditions and osteoporosis. The clinic is open 8 a.m. to 5 p.m. Monday through Friday. New patients are taken by referral.

More on the Arthritis Clinic

Dr. Jacob Aelion, Dr. Satish Odhav and Dr. Nimesh Dayal have a busy rheumatology practice at the Arthritis Clinic in Jackson, but they also find time to further knowledge in medicine in general and rheumatology in particular both at the local and the national level. They maintain clinical faculty positions with the University of Tennessee and have presented original observations at national and international professional meetings. They have contributed to statewide organizations such as the Tennessee Rheumatology Society, which Dr. Aelion helped to found, and the West Tennessee Arthritis Foundation, in which Dr. Odhav is involved, by helping with the annual arthritis walk and other activities. They are instrumental in putting together the annual Jackson-Madison County General Hospital General Medicine Symposium that has recently celebrated its tenth anniversary and has been well received by the West Tennessee medical community.

“One of the achievements that we have been especially proud of has been the integration of an excellent clinical trial program in our practice,” Dr Aelion says. “The treatment of autoimmune conditions is undergoing a veritable revolution with several new treatment modalities that are having a tremendous beneficial impact in conditions that looked hopeless only a few years ago. In our clinic we are able to offer these cutting-edge, new medications two to four years before they become available to the general public and usually at no cost to the patients” he adds.

“We have recently joined a select group of rheumatology clinical trial centers in the nation, putting us among the top five percent,” says Dr. Odhav. “And we are very proud of that.”